Comments
Loading...

Lumexa Imaging Holdings Analyst Ratings

LMRINASDAQ
Logo brought to you by Benzinga Data
$16.60
-1.13-6.37%
Last update: Jan 9, 10:10 AM
Consensus Rating1
Outperform
Highest Price Target1
$23.00
Lowest Price Target1
$22.00
Consensus Price Target1
$22.67

Lumexa Imaging Holdings Analyst Ratings and Price Targets | NASDAQ:LMRI | Benzinga

Lumexa Imaging Holdings Inc has a consensus price target of $22.67 based on the ratings of 7 analysts. The high is $23 issued by Raymond James on January 5, 2026. The low is $22 issued by Wells Fargo on January 5, 2026. The 3 most-recent analyst ratings were released by Raymond James, Barclays, and Wells Fargo on January 5, 2026, respectively. With an average price target of $22.67 between Raymond James, Barclays, and Wells Fargo, there's an implied 36.55% upside for Lumexa Imaging Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

7
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Raymond James
Barclays
Wells Fargo
Deutsche Bank
Leerink Partners

1calculated from analyst ratings

Analyst Ratings for Lumexa Imaging Holdings

Get Alert
Jan 5, 2026
38.55%
23
Previous
Initiates
Current
Outperform
Get Alert
Jan 5, 2026
38.55%
23
Previous
Initiates
Current
Overweight
Get Alert
Jan 5, 2026
32.53%
22
Previous
Initiates
Current
Overweight
Get Alert
Jan 5, 2026
Previous
Initiates
Current
Outperform
Get Alert
Jan 5, 2026
32.53%
22
Previous
Initiates
Current
Buy
Get Alert
Jan 5, 2026
38.55%
23
Previous
Initiates
Current
Outperform
Get Alert
Jan 5, 2026
38.55%
23
Previous
Initiates
Current
Buy
Get Alert

FAQ

Q

What is the target price for Lumexa Imaging Holdings (LMRI) stock?

A

The latest price target for Lumexa Imaging Holdings (NASDAQ:LMRI) was reported by Raymond James on January 5, 2026. The analyst firm set a price target for $23.00 expecting LMRI to rise to within 12 months (a possible 38.55% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Lumexa Imaging Holdings (LMRI)?

A

The latest analyst rating for Lumexa Imaging Holdings (NASDAQ:LMRI) was provided by Raymond James, and Lumexa Imaging Holdings initiated their outperform rating.

Q

When was the last upgrade for Lumexa Imaging Holdings (LMRI)?

A

There is no last upgrade for Lumexa Imaging Holdings

Q

When was the last downgrade for Lumexa Imaging Holdings (LMRI)?

A

There is no last downgrade for Lumexa Imaging Holdings.

Q

When is the next analyst rating going to be posted or updated for Lumexa Imaging Holdings (LMRI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumexa Imaging Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumexa Imaging Holdings was filed on January 5, 2026 so you should expect the next rating to be made available sometime around January 5, 2027.

Q

Is the Analyst Rating Lumexa Imaging Holdings (LMRI) correct?

A

While ratings are subjective and will change, the latest Lumexa Imaging Holdings (LMRI) rating was a initiated with a price target of $0.00 to $23.00. The current price Lumexa Imaging Holdings (LMRI) is trading at is $16.60, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.